Run-lin Gao
Pharmaceuticals
Zensun Sci & Tech Co., Ltd.
China
Biography
Dr. Gao is the principal investigator of all the clinical trials for NeucardinTM that have been conducted in China. He worked as the head of the Cardiovascular Disease Institute of the Chinese Academy of Medical Sciences and Fuwai Hospital, and is now taking responsibility as the Vice Chairman of the Chinese Doctor Association, Standing Director of the Chinese Medical Association, FACC, and Chief Editor of the Chinese Medical Journal. Professor Gao was the first to perform emergency percutaneous transluminal coronary angioplasty for acute myocardial infarction and the first to report the use of coronary stenting and drug-eluting stents in China. He has received seven academic awards, and has more than 490 original publications.
Research Interest
Business, Management, Finance, Pharmaceuticals, Pharmacology
